Chaotic, Disorganized, and Mismanaged - werkgeversreview Scientist bij Zymeworks

1,0
27 mei 2022
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Zanidatamab is an excellent asset

Minpunten

- Talented & experienced group of scientists that developed Zanidatamab are no longer at Zymeworks - Senior Scientific leadership does not have the necessary drug development experience - Success of pipeline projects doesn't matter, company is treading water to get to a sale - CEO has no history developing medicine or building companies. His history is dominated by breaking apart and selling assets. - Former CFO, at least partly responsible for the cratering of the company, is allowed to remain and transition to COO. - Company still talks about its values as though they determine corporate behavior

Ontdek andere reviews over Zymeworks

5,0
15 jan 2025
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Good discipline nice work experience

Minpunten

No bad experience it was good

4,0
10 apr 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Good mangement okay salary good

Minpunten

Nothing to say from me

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle